“…In the past two decades, genome-scale metabolic modeling has rapidly advanced in terms of number and quality of available network reconstructions as well as modeling approaches based on flux balance analysis (FBA). FBA approaches have been applied to study microbial [1] , [2] , [3] , human [4] , [5] , and plant metabolic networks [6] , [7] , [8] , [9] , [10] and aided, for instance, designing microbial strains for optimized compound production [11] , [12] , understanding human diseases [13] , [14] , [15] , and elucidating constraints in plant metabolism [16] , [17] , [18] . Recent developments enable the study of interacting systems such as the human gut microbiome [19] , [20] , [21] , [22] or tissues and cell types in humans [4] , [13] , [23] , [24] and plants [25] , [26] , [27] , [28] , [29] , [30] , [31] .…”